ketamine has been researched along with Cystitis in 84 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
Cystitis: Inflammation of the URINARY BLADDER, either from bacterial or non-bacterial causes. Cystitis is usually associated with painful urination (dysuria), increased frequency, urgency, and suprapubic pain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ketamine cystitis (KC) is a chronic bladder inflammation leading to urinary urgency, frequency, and pain." | 9.12 | Molecular pathways underlying tissue injuries in the bladder with ketamine cystitis. ( Chen, H; Ergu, E; Huang, R; Liang, J; Luo, C; Qiao, H; Xie, X; Xing, H; Yang, J; Zhou, L, 2021) |
| "Long-term or recreational use of ketamine affects the urinary system and can result in ketamine-induced cystitis (KIC)." | 9.12 | Rodent models of ketamine-induced cystitis. ( Berger, G; Cox, A; Kelly, MEM; Lehmann, C; Sultana, S, 2021) |
| "Ketamine-related cystitis is characterized by ketamine-induced urinary frequency and bladder pain." | 8.91 | Possible pathophysiology of ketamine-related cystitis and associated treatment strategies. ( Hsu, YH; Jhang, JF; Kuo, HC, 2015) |
| "To determine the diagnosis, treatment, and pathogenesis of ketamine-associated cystitis." | 8.89 | [Diagnosis and treatment of ketamine-associated cystitis: a report of 3 cases and literature review]. ( Ding, J; Huang, K; Huang, L; Li, D; Li, Y; Luo, K; Tang, Z; Wang, G; Zhou, J, 2013) |
| "In this study, using transcriptomic and correlation analyses of metabolomics, we identified pathways that may be potential targets for the prevention and treatment of ketamine-induced bladder fibrosis." | 8.12 | Transcriptomic analysis of bladder tissue in a rat model of ketamine-induced bladder fibrosis. ( Li, H; Li, K; Tang, Z; Wang, Z; Zhu, Q, 2022) |
| "The present study attempted to elucidate whether intravesical instillation of platelet-rich plasma (PRP) could decrease bladder inflammation and ameliorate bladder hyperactivity in ketamine ulcerative cystitis (KIC) rat model." | 8.12 | Therapeutic Effect of Platelet-Rich Plasma Improves Bladder Overactivity in the Pathogenesis of Ketamine-Induced Ulcerative Cystitis in a Rat Model. ( Chuang, SM; Chueh, KS; Huang, KH; Juan, TJ; Juan, YS; Lee, YC; Lin, RJ; Long, CY; Lu, JH; Shen, MC; Sun, TW, 2022) |
| "Stronger contractility and smaller bladder capacity are common symptoms in ketamine cystitis (KC)." | 8.02 | Smaller bladder capacity and stronger bladder contractility in patients with ketamine cystitis are associated with elevated TRPV1 and TRPV4. ( Hsu, YH; Jhang, JF; Jiang, YH; Kuo, HC; Yang, HH; Zhai, WJ, 2021) |
| "Long-term abuse of ketamine causes ketamine-induced cystitis." | 7.96 | Extracellular vesicles enhance oxidative stress through P38/NF-kB pathway in ketamine-induced ulcerative cystitis. ( Chen, SH; He, PJ; Jiang, ZW; Lu, Y; Mi, H; Xi, XJ; Zeng, JJ, 2020) |
| "To investigate the mechanism of bladder nerve hyperplasia and fibrosis in the patients with ketamine-associated cystitis (KC)." | 7.91 | Upregulation of neurotrophins and transforming growth factor-β expression in the bladder may lead to nerve hyperplasia and fibrosis in patients with severe ketamine-associated cystitis. ( Birder, LA; Hsu, YH; Jhang, JF; Kuo, HC; Wang, HJ, 2019) |
| "We investigated the effects of Ba-Wei-Die-Huang-Wan (BWDHW) on ketamine-induced cystitis (KIC) in a rat model." | 7.91 | Ba-Wei-Die-Huang-Wan (Hachimi-jio-gan) can ameliorate ketamine-induced cystitis by modulating neuroreceptors, inflammatory mediators, and fibrogenesis in a rat model. ( Chuang, YC; Lee, WC; Su, CH; Tain, YL; Tsai, CN; Yu, CC, 2019) |
| "The present study investigated the methylation of CpG sites in the cyclooxygenase (COX)‑2 promoter via nuclear factor (NF)‑κB transcriptional regulation and elucidated its effect on the COX‑2 transcriptional expression in a ketamine‑induced ulcerative cystitis (KIC) animal model." | 7.91 | Epigenetic regulation of COX‑2 expression by DNA hypomethylation via NF‑κB activation in ketamine‑induced ulcerative cystitis. ( Chuang, SM; Hsiao, HP; Juan, YS; Lee, YC; Lin, KL; Long, CY; Lu, JH; Tsai, CC; Wu, WJ; Yang, HJ, 2019) |
| "Ketamine abusers may develop ulcerative cystitis and severe lower urinary tract symptoms, which is a medical dilemma." | 7.88 | Potential Orphan Drug Therapy of Intravesical Liposomal Onabotulinumtoxin-A for Ketamine-Induced Cystitis by Mucosal Protection and Anti-inflammation in a Rat Model. ( Chuang, YC; Lee, WC; Su, CH; Tain, YL; Tsai, CN; Yu, CC, 2018) |
| "Ketamine abuse is an emerging issue in many countries, and ketamine cystitis (KC) is a growing disease which more and more urologists may encounter with." | 7.88 | Complete reversal of the clinical symptoms and image morphology of ketamine cystitis after intravesical hyaluronic acid instillation: A case report. ( Cha, TL; Liu, CY; Ou, YL; Tsao, CW; Wu, ST, 2018) |
| "Ketamine-induced ulcerative cystitis (KIC) initially damaged the bladder mucosa and induced contracted bladder thereafter." | 7.85 | Elucidating Mechanisms of Bladder Repair after Hyaluronan Instillation in Ketamine-Induced Ulcerative Cystitis in Animal Model. ( Chuang, SM; Ho, WT; Juan, YS; Lee, YC; Lee, YL; Lin, KL; Lu, MC; Wu, BN; Wu, WJ; Yuan, SF, 2017) |
| "Ketamine-induced cystitis (KC) among chronic ketamine young abusers has increased dramatically and it has brought attention for Urologists." | 7.85 | The putative involvement of actin-binding proteins and cytoskeleton proteins in pathological mechanisms of ketamine cystitis-Revealed by a prospective pilot study using proteomic approaches. ( Kuo, HC; Yang, HH; Zhai, WJ, 2017) |
| "Bladder wall fibrosis is a major complication of ketamine-induced cystitis (KC), but the underlying pathogenesis is poorly understood." | 7.85 | Ketamine-induced bladder fibrosis involves epithelial-to-mesenchymal transition mediated by transforming growth factor-β1. ( Chen, J; Chen, Y; Gu, D; Wang, J; Wu, P; Zhang, G; Zhao, J, 2017) |
| "Objective Ketamine-associated cystitis (KAC) has been described in a few case reports, but its treatment in a relatively large number of patients has not been documented." | 7.85 | Effective treatment of ketamine-associated cystitis with botulinum toxin type a injection combined with bladder hydrodistention. ( Huang, Z; Lai, H; Wang, S; Wei, L; Zeng, J; Zheng, D; Zhong, L; Zou, W, 2017) |
| "Abuse of the hallucinogenic drug ketamine promotes the development of lower urinary tract symptoms that resemble interstitial cystitis." | 7.83 | Mesenchymal stem cells protect against the tissue fibrosis of ketamine-induced cystitis in rat bladder. ( Choi, SJ; Choo, MS; Heo, J; Kim, A; Kim, SW; Kim, Y; Lee, S; Lim, J; Oh, W; Shin, DM; Shin, JH; Song, M; Yoon, SJ; Yu, HY, 2016) |
| "To establish whether the urothelial ulceration observed in ketamine-induced cystitis is triggered by urinary or systemic factors." | 7.83 | A Rare Urachal Cyst in a Case of Ketamine-induced Cystitis Provides Mechanistic Insights. ( Baker, SC; Fulford, S; Garthwaite, M; Kidger, E; Southgate, J; Stahlschmidt, J, 2016) |
| "The aim of the current study was to evaluate the histopathological features of inflammation and the expression levels of inflammatory markers in tissue samples from patients with ketamine‑induced cystitis." | 7.81 | Histopathological assessment of inflammation and expression of inflammatory markers in patients with ketamine-induced cystitis. ( Cha, TL; Chiueh, TS; Lee, HS; Lin, HA; Lin, HC; Lin, YC; Meng, E, 2015) |
| "Long-term ketamine abuse is known to affect the lower urinary tract and produce symptoms of cystitis." | 7.80 | Long-term ketamine abuse induces cystitis in rats by impairing the bladder epithelial barrier. ( Gu, D; Huang, J; Shan, Z; Wu, P; Yin, Y; Zheng, S, 2014) |
| "Ketamine cystitis is a complex problem whose exact pathological mechanism and natural history remain unknown." | 7.80 | Ketamine cystitis: practical considerations in management. ( Chetwood, A; Coker, C; Misra, S; Thomas, P, 2014) |
| "The histological findings were distinguishing features of ketamine cystitis and were not present in other painful bladder conditions." | 7.79 | Nerve hyperplasia: a unique feature of ketamine cystitis. ( Baker, SC; Eardley, I; Fulford, S; Gillatt, D; Hinley, J; Marsh, F; Oxley, J; Southgate, J; Stahlschmidt, J, 2013) |
| "The aims of the present study were to investigate voiding patterns, tissue constituents and the expressions of cyclooxygenase-2 (COX-2) and nitric oxide synthase (NOS) involved in ketamine-induced ulcerative cystitis in rat urinary bladder." | 7.79 | Dual involvements of cyclooxygenase and nitric oxide synthase expressions in ketamine-induced ulcerative cystitis in rat bladder. ( Chang, WC; Chuang, SM; Jang, MY; Juan, YS; Lee, HH; Levin, RM; Li, YL; Liu, KM; Wu, WJ, 2013) |
| "Ketamine can lead to reactive urothelial changes that can mimic carcinoma in situ, but the long-term cancer risk remains unknown." | 7.75 | Ketamine cystitis as a mimic of carcinoma in situ. ( Adams, S; Cottrell, AM; Gillatt, D; Oxley, JD, 2009) |
| "This case series has described a new clinical entity of severe ulcerative cystitis as a result of chronic ketamine use." | 7.74 | Ketamine-associated ulcerative cystitis: a new clinical entity. ( Dickson, B; Shahani, R; Stewart, RJ; Streutker, C, 2007) |
| "Ketamine is a dissociative anesthetic, historically used in a clinical setting for the induction and maintenance of anesthesia." | 7.01 | Current approaches for the treatment of ketamine-induced cystitis. ( Lehmann, C; Miab, ZR; Scott, C; Zhou, J, 2023) |
| "Ketamine is a versatile analgesic that has become an increasingly popular recreational drug." | 5.62 | Recreational ketamine-induced cholangiopathy and ulcerative cystitis. ( Freyre, K; Opsha, O; Opsha, Y; Vu, DM, 2021) |
| "Ketamine is an ionotropic glutamatergic N‑methyl‑D‑aspartate receptor antagonist, which is widely used among recreational drug abusers." | 5.48 | Clinical significance of interleukin‑6 and inducible nitric oxide synthase in ketamine‑induced cystitis. ( Chen, SK; Chien, CC; Huang, CJ; Lee, FK; Wang, YC; Wu, ST, 2018) |
| "Ketamine abuse has become a global phenomenon in recent years." | 5.46 | Clinical Outcome of Augmentation Enterocystoplasty for Patients with Ketamine-induced Cystitis. ( Jhang, JF; Kuo, HC; Lee, YK, 2017) |
| "Ketamine-treated rats were found to display bladder hyperactivity." | 5.42 | Ketamine-induced ulcerative cystitis and bladder apoptosis involve oxidative stress mediated by mitochondria and the endoplasmic reticulum. ( Chuang, SM; Ho, WT; Jang, MY; Juan, YS; Lee, YL; Lin, RJ; Liu, KM; Long, CY; Lu, JH; Lu, MC; Wang, CC; Wu, WJ, 2015) |
| "Treatment with ketamine + COX-2 inhibitor prevented these bladder dysfunctions." | 5.42 | Translocation of NF-κB and expression of cyclooxygenase-2 are enhanced by ketamine-induced ulcerative cystitis in rat bladder. ( Chang, WC; Chuang, SM; Huang, YS; Jang, MY; Juan, YS; Lee, YL; Long, CY; Lu, JH; Wong, JH; Wu, WJ, 2015) |
| "The ketamine usage pattern was recorded: initiation, administration route, dose in the last month and frequency of usage." | 5.38 | [Cystitis and ketamine associated bladder dysfunction]. ( Arango, O; Bielsa, O; Castillo, C; García-Larrosa, A; Lorente, JA; Ventura, M, 2012) |
| "Ketamine-associated uropathy frequently involves frequency, urgency, and suprapubic pain; upper urinary tract involvement is less common." | 5.22 | Systematic review and meta-analysis of ketamine-associated uropathy. ( Chan, EOT; Chan, VWS; Cheung, V; Ng, CF; Tang, TST; Teoh, JYC; Wong, MCS; Yee, CH, 2022) |
| "Ketamine-related cystitis is characterized by ketamine-induced urinary frequency and bladder pain." | 4.91 | Possible pathophysiology of ketamine-related cystitis and associated treatment strategies. ( Hsu, YH; Jhang, JF; Kuo, HC, 2015) |
| "To determine the diagnosis, treatment, and pathogenesis of ketamine-associated cystitis." | 4.89 | [Diagnosis and treatment of ketamine-associated cystitis: a report of 3 cases and literature review]. ( Ding, J; Huang, K; Huang, L; Li, D; Li, Y; Luo, K; Tang, Z; Wang, G; Zhou, J, 2013) |
| "The implications of these findings are drawn out for treatment of ketamine-induced ulcerative cystitis in which interventions from urologists and from addiction specialists should be coordinated." | 4.88 | Ketamine use: a review. ( Curran, HV; Morgan, CJ, 2012) |
| "The present study attempted to elucidate whether intravesical instillation of platelet-rich plasma (PRP) could decrease bladder inflammation and ameliorate bladder hyperactivity in ketamine ulcerative cystitis (KIC) rat model." | 4.12 | Therapeutic Effect of Platelet-Rich Plasma Improves Bladder Overactivity in the Pathogenesis of Ketamine-Induced Ulcerative Cystitis in a Rat Model. ( Chuang, SM; Chueh, KS; Huang, KH; Juan, TJ; Juan, YS; Lee, YC; Lin, RJ; Long, CY; Lu, JH; Shen, MC; Sun, TW, 2022) |
| "In this study, using transcriptomic and correlation analyses of metabolomics, we identified pathways that may be potential targets for the prevention and treatment of ketamine-induced bladder fibrosis." | 4.12 | Transcriptomic analysis of bladder tissue in a rat model of ketamine-induced bladder fibrosis. ( Li, H; Li, K; Tang, Z; Wang, Z; Zhu, Q, 2022) |
| "Background Ketamine-related cystitis (KC) has been researched in many clinical studies, but its exact mechanism is ambiguous and needs further research." | 4.02 | Ketamine enhances autophagy and endoplasmic reticulum stress in rats and SV-HUC-1 cells via activating IRE1-TRAF2-ASK1-JNK pathway. ( Li, Y; Qiao, H; Shan, Z; Wu, D; Yu, Y, 2021) |
| "Long-term abuse of ketamine causes ketamine-induced cystitis." | 3.96 | Extracellular vesicles enhance oxidative stress through P38/NF-kB pathway in ketamine-induced ulcerative cystitis. ( Chen, SH; He, PJ; Jiang, ZW; Lu, Y; Mi, H; Xi, XJ; Zeng, JJ, 2020) |
| "To investigate the mechanism of bladder nerve hyperplasia and fibrosis in the patients with ketamine-associated cystitis (KC)." | 3.91 | Upregulation of neurotrophins and transforming growth factor-β expression in the bladder may lead to nerve hyperplasia and fibrosis in patients with severe ketamine-associated cystitis. ( Birder, LA; Hsu, YH; Jhang, JF; Kuo, HC; Wang, HJ, 2019) |
| "We investigated the effects of Ba-Wei-Die-Huang-Wan (BWDHW) on ketamine-induced cystitis (KIC) in a rat model." | 3.91 | Ba-Wei-Die-Huang-Wan (Hachimi-jio-gan) can ameliorate ketamine-induced cystitis by modulating neuroreceptors, inflammatory mediators, and fibrogenesis in a rat model. ( Chuang, YC; Lee, WC; Su, CH; Tain, YL; Tsai, CN; Yu, CC, 2019) |
| "Many clinical studies have been conducted on ketamine-associated cystitis." | 3.91 | Ketamine induces endoplasmic reticulum stress in rats and SV-HUC-1 human uroepithelial cells by activating NLRP3/TXNIP aix. ( Cui, L; Guo, W; Jiang, X; Li, D; Ma, Y; Shan, Z; Wan, F; Yu, S; Zhang, C, 2019) |
| "The present study investigated the methylation of CpG sites in the cyclooxygenase (COX)‑2 promoter via nuclear factor (NF)‑κB transcriptional regulation and elucidated its effect on the COX‑2 transcriptional expression in a ketamine‑induced ulcerative cystitis (KIC) animal model." | 3.91 | Epigenetic regulation of COX‑2 expression by DNA hypomethylation via NF‑κB activation in ketamine‑induced ulcerative cystitis. ( Chuang, SM; Hsiao, HP; Juan, YS; Lee, YC; Lin, KL; Long, CY; Lu, JH; Tsai, CC; Wu, WJ; Yang, HJ, 2019) |
| "Ketamine abuse is an emerging issue in many countries, and ketamine cystitis (KC) is a growing disease which more and more urologists may encounter with." | 3.88 | Complete reversal of the clinical symptoms and image morphology of ketamine cystitis after intravesical hyaluronic acid instillation: A case report. ( Cha, TL; Liu, CY; Ou, YL; Tsao, CW; Wu, ST, 2018) |
| "Twenty-three patients with ketamine-induced cystitis (KC) and 16 control volunteers were recruited." | 3.85 | Activation of the mTOR dependent signaling pathway underlies ketamine-induced uropathy. ( Lin, AT; Lin, CC; Yang, AH, 2017) |
| "Bladder wall fibrosis is a major complication of ketamine-induced cystitis (KC), but the underlying pathogenesis is poorly understood." | 3.85 | Ketamine-induced bladder fibrosis involves epithelial-to-mesenchymal transition mediated by transforming growth factor-β1. ( Chen, J; Chen, Y; Gu, D; Wang, J; Wu, P; Zhang, G; Zhao, J, 2017) |
| "Ketamine-induced ulcerative cystitis (KIC) initially damaged the bladder mucosa and induced contracted bladder thereafter." | 3.85 | Elucidating Mechanisms of Bladder Repair after Hyaluronan Instillation in Ketamine-Induced Ulcerative Cystitis in Animal Model. ( Chuang, SM; Ho, WT; Juan, YS; Lee, YC; Lee, YL; Lin, KL; Lu, MC; Wu, BN; Wu, WJ; Yuan, SF, 2017) |
| "Abuse of the hallucinogenic drug ketamine promotes the development of lower urinary tract symptoms that resemble interstitial cystitis." | 3.83 | Mesenchymal stem cells protect against the tissue fibrosis of ketamine-induced cystitis in rat bladder. ( Choi, SJ; Choo, MS; Heo, J; Kim, A; Kim, SW; Kim, Y; Lee, S; Lim, J; Oh, W; Shin, DM; Shin, JH; Song, M; Yoon, SJ; Yu, HY, 2016) |
| "To establish whether the urothelial ulceration observed in ketamine-induced cystitis is triggered by urinary or systemic factors." | 3.83 | A Rare Urachal Cyst in a Case of Ketamine-induced Cystitis Provides Mechanistic Insights. ( Baker, SC; Fulford, S; Garthwaite, M; Kidger, E; Southgate, J; Stahlschmidt, J, 2016) |
| "Recreational abuse of ketamine has been associated with the emergence of a new bladder pain syndrome, ketamine-induced cystitis, characterized by chronic inflammation and urothelial ulceration." | 3.83 | Ketamine-Induced Apoptosis in Normal Human Urothelial Cells: A Direct, N-Methyl-d-Aspartate Receptor-Independent Pathway Characterized by Mitochondrial Stress. ( Baker, SC; Georgopoulos, NT; Shabir, S; Southgate, J, 2016) |
| "Ketamine-associated cystitis is a well-recognised syndrome; yet upper urinary tract involvement remains poorly understood." | 3.81 | Autotransplantation for the management of ketamine ureteritis. ( Game, D; O'Brien, T; Olsburgh, J; Raison, NT, 2015) |
| "Ketamine cystitis is a complex problem whose exact pathological mechanism and natural history remain unknown." | 3.80 | Ketamine cystitis: practical considerations in management. ( Chetwood, A; Coker, C; Misra, S; Thomas, P, 2014) |
| "To report our early results of augmentation enterocystoplasty (AE) for severe bladder pain associated with chronic ketamine cystitis (KC)." | 3.80 | Augmentation enterocystoplasty is effective in relieving refractory ketamine-related bladder pain. ( Chung, SD; Kuo, HC; Wang, CC, 2014) |
| "Long-term ketamine abuse is known to affect the lower urinary tract and produce symptoms of cystitis." | 3.80 | Long-term ketamine abuse induces cystitis in rats by impairing the bladder epithelial barrier. ( Gu, D; Huang, J; Shan, Z; Wu, P; Yin, Y; Zheng, S, 2014) |
| "The histological findings were distinguishing features of ketamine cystitis and were not present in other painful bladder conditions." | 3.79 | Nerve hyperplasia: a unique feature of ketamine cystitis. ( Baker, SC; Eardley, I; Fulford, S; Gillatt, D; Hinley, J; Marsh, F; Oxley, J; Southgate, J; Stahlschmidt, J, 2013) |
| "Long-term ketamine abuse induces phosphorylation of transgelin in the bladder wall, and this might play an important role in the pathogenesis of ketamine-associated cystitis." | 3.79 | Effects of long-term ketamine administration on rat bladder protein levels: a proteomic investigation using two-dimensional difference gel electrophoresis system. ( Gu, D; Huang, J; Shan, Z; Wu, P; Yin, Y; Zheng, S, 2013) |
| " What's known on the subject? and What does the study add? Case series have described lower urinary tract symptoms associated with ketamine use including severe pain, frequency, haematuria and dysuria." | 3.78 | The prevalence and natural history of urinary symptoms among recreational ketamine users. ( Cottrell, AM; Gillatt, DA; Mitcheson, L; Winstock, AR, 2012) |
| "Ketamine can lead to reactive urothelial changes that can mimic carcinoma in situ, but the long-term cancer risk remains unknown." | 3.75 | Ketamine cystitis as a mimic of carcinoma in situ. ( Adams, S; Cottrell, AM; Gillatt, D; Oxley, JD, 2009) |
| "This case series has described a new clinical entity of severe ulcerative cystitis as a result of chronic ketamine use." | 3.74 | Ketamine-associated ulcerative cystitis: a new clinical entity. ( Dickson, B; Shahani, R; Stewart, RJ; Streutker, C, 2007) |
| ") administration of 200mg/kg cyclophosphamide, an antitumoral agent, modified the behaviour of rats with cystitis induced by acrolein, a toxic urinary by-product of cyclophosphamide." | 3.71 | Involvement of N-methyl-D-aspartate receptors in nociception in the cyclophosphamide-induced vesical pain model in the conscious rat. ( Boucher, M; Coudoré-Civiale, MA; Eschalier, A; Méen, M; Parry, L, 2002) |
| "Ketamine is a dissociative anesthetic, historically used in a clinical setting for the induction and maintenance of anesthesia." | 3.01 | Current approaches for the treatment of ketamine-induced cystitis. ( Lehmann, C; Miab, ZR; Scott, C; Zhou, J, 2023) |
| "Ketamine is a general anesthetic." | 2.66 | What urologists need to know about ketamine-induced uropathy: A systematic review. ( Castellani, D; Dellabella, M; Gregori, A; Gubbiotti, M; Gudaru, K; Pirola, GM; Rubilotta, E, 2020) |
| "Ketamine is a versatile analgesic that has become an increasingly popular recreational drug." | 1.62 | Recreational ketamine-induced cholangiopathy and ulcerative cystitis. ( Freyre, K; Opsha, O; Opsha, Y; Vu, DM, 2021) |
| "Ketamine abuse has become a global phenomenon in recent years." | 1.46 | Clinical Outcome of Augmentation Enterocystoplasty for Patients with Ketamine-induced Cystitis. ( Jhang, JF; Kuo, HC; Lee, YK, 2017) |
| "Ketamine abuse causes lower urinary tract symptoms, with the underlying pathophysiology poorly understood." | 1.43 | Intact urothelial barrier function in a mouse model of ketamine-induced voiding dysfunction. ( MacIver, B; Ong, TA; Rajandram, R; Razack, AH; Yu, W; Zeidel, M, 2016) |
| "Ketamine is a short-acting anaesthetic agent that has gained popularity as a 'club drug' due to its hallucinogenic effects." | 1.42 | The clinical presentation and diagnosis of ketamine-associated urinary tract dysfunction in Singapore. ( Aydin, H; Kuo, T; Ng, LG; Sundaram, P; Yek, J, 2015) |
| "Ketamine-treated rats were found to display bladder hyperactivity." | 1.42 | Ketamine-induced ulcerative cystitis and bladder apoptosis involve oxidative stress mediated by mitochondria and the endoplasmic reticulum. ( Chuang, SM; Ho, WT; Jang, MY; Juan, YS; Lee, YL; Lin, RJ; Liu, KM; Long, CY; Lu, JH; Lu, MC; Wang, CC; Wu, WJ, 2015) |
| "Ketamine bladder is a new clinical entity that may lead to irreversible damage to the urinary system." | 1.38 | Illicit ketamine and its bladder consequences: is it irreversible? ( Gupta, S; Jalil, R, 2012) |
| "The ketamine usage pattern was recorded: initiation, administration route, dose in the last month and frequency of usage." | 1.38 | [Cystitis and ketamine associated bladder dysfunction]. ( Arango, O; Bielsa, O; Castillo, C; García-Larrosa, A; Lorente, JA; Ventura, M, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (9.52) | 29.6817 |
| 2010's | 58 (69.05) | 24.3611 |
| 2020's | 18 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Yu, W | 4 |
| Kutscher, E | 1 |
| Greene, RE | 1 |
| Li, H | 1 |
| Li, K | 1 |
| Zhu, Q | 1 |
| Tang, Z | 3 |
| Wang, Z | 2 |
| Chung, SD | 2 |
| Praveen Rajneesh, C | 1 |
| Chen, KC | 1 |
| Tai, HC | 1 |
| Chang, ML | 1 |
| Tseng, XW | 1 |
| Cheng, JH | 1 |
| Tsai, WK | 1 |
| Chiang, HS | 1 |
| Wu, YN | 1 |
| Tan, S | 1 |
| Zhang, L | 1 |
| Wang, G | 2 |
| Zhu, X | 1 |
| Chueh, KS | 1 |
| Huang, KH | 1 |
| Lu, JH | 4 |
| Juan, TJ | 1 |
| Chuang, SM | 6 |
| Lin, RJ | 2 |
| Lee, YC | 3 |
| Long, CY | 4 |
| Shen, MC | 1 |
| Sun, TW | 1 |
| Juan, YS | 6 |
| Chan, EOT | 3 |
| Chan, VWS | 3 |
| Tang, TST | 3 |
| Cheung, V | 3 |
| Wong, MCS | 3 |
| Yee, CH | 4 |
| Ng, CF | 5 |
| Teoh, JYC | 3 |
| Zhou, J | 2 |
| Scott, C | 1 |
| Miab, ZR | 1 |
| Lehmann, C | 2 |
| Jhang, JF | 6 |
| Wang, HJ | 1 |
| Hsu, YH | 4 |
| Birder, LA | 2 |
| Kuo, HC | 8 |
| Lee, WC | 2 |
| Tain, YL | 2 |
| Chuang, YC | 2 |
| Tsai, CN | 2 |
| Yu, CC | 2 |
| Su, CH | 2 |
| Cui, L | 1 |
| Jiang, X | 1 |
| Zhang, C | 1 |
| Li, D | 2 |
| Yu, S | 1 |
| Wan, F | 1 |
| Ma, Y | 1 |
| Guo, W | 1 |
| Shan, Z | 4 |
| Castellani, D | 1 |
| Pirola, GM | 1 |
| Gubbiotti, M | 1 |
| Rubilotta, E | 1 |
| Gudaru, K | 1 |
| Gregori, A | 1 |
| Dellabella, M | 1 |
| Xi, XJ | 1 |
| Zeng, JJ | 1 |
| Lu, Y | 1 |
| Chen, SH | 1 |
| Jiang, ZW | 1 |
| He, PJ | 1 |
| Mi, H | 1 |
| Chen, H | 2 |
| Vandorpe, DH | 1 |
| Xie, X | 2 |
| Alper, SL | 1 |
| Zeidel, ML | 1 |
| Ou, SH | 1 |
| Wu, LY | 1 |
| Chen, HY | 1 |
| Huang, CW | 1 |
| Hsu, CY | 1 |
| Chen, CL | 1 |
| Chou, KJ | 1 |
| Fang, HC | 1 |
| Lee, PT | 1 |
| Hartjes, A | 1 |
| Hofer, M | 1 |
| Marlin, D | 1 |
| Hohenauer, P | 1 |
| Vu, DM | 1 |
| Freyre, K | 1 |
| Opsha, O | 1 |
| Opsha, Y | 1 |
| Yang, HH | 2 |
| Jiang, YH | 1 |
| Zhai, WJ | 2 |
| Liang, J | 1 |
| Huang, R | 1 |
| Luo, C | 1 |
| Yang, J | 2 |
| Xing, H | 1 |
| Zhou, L | 1 |
| Qiao, H | 2 |
| Ergu, E | 1 |
| Sultana, S | 1 |
| Berger, G | 1 |
| Cox, A | 1 |
| Kelly, MEM | 1 |
| Yu, Y | 1 |
| Wu, D | 1 |
| Li, Y | 2 |
| Wang, J | 1 |
| Chen, Y | 1 |
| Gu, D | 3 |
| Zhang, G | 1 |
| Chen, J | 1 |
| Zhao, J | 1 |
| Wu, P | 3 |
| Lee, YK | 1 |
| Zeng, J | 1 |
| Lai, H | 1 |
| Zheng, D | 1 |
| Zhong, L | 1 |
| Huang, Z | 1 |
| Wang, S | 1 |
| Zou, W | 1 |
| Wei, L | 1 |
| Lee, YL | 3 |
| Lin, KL | 2 |
| Lu, MC | 2 |
| Wu, BN | 1 |
| Wu, WJ | 5 |
| Yuan, SF | 1 |
| Ho, WT | 2 |
| Huang, CJ | 1 |
| Lee, FK | 1 |
| Chen, SK | 1 |
| Chien, CC | 1 |
| Wu, ST | 2 |
| Wang, YC | 1 |
| Sihra, N | 1 |
| Ockrim, J | 1 |
| Wood, D | 2 |
| Chen, YC | 3 |
| Ou, YL | 1 |
| Liu, CY | 1 |
| Cha, TL | 2 |
| Tsao, CW | 1 |
| Hsiao, HP | 1 |
| Tsai, CC | 1 |
| Yang, HJ | 1 |
| Wei, YB | 1 |
| Yang, JR | 1 |
| Cote, AL | 1 |
| Rolland, B | 1 |
| Cottencin, O | 1 |
| Wang, CC | 2 |
| Huang, L | 1 |
| Ding, J | 1 |
| Luo, K | 1 |
| Huang, K | 1 |
| Baker, SC | 3 |
| Stahlschmidt, J | 2 |
| Oxley, J | 1 |
| Hinley, J | 1 |
| Eardley, I | 1 |
| Marsh, F | 1 |
| Gillatt, D | 2 |
| Fulford, S | 2 |
| Southgate, J | 3 |
| García-Larrosa, A | 2 |
| Capdevila, S | 1 |
| Laborda, A | 1 |
| Vargas, C | 1 |
| Connors, NJ | 1 |
| Grino, A | 1 |
| Tunik, MG | 1 |
| Hoffman, RS | 1 |
| Misra, S | 1 |
| Chetwood, A | 1 |
| Coker, C | 1 |
| Thomas, P | 1 |
| Tran, VH | 1 |
| Nelson, M | 1 |
| Nogar, J | 1 |
| Bramante, RM | 1 |
| Huang, J | 2 |
| Yin, Y | 2 |
| Zheng, S | 2 |
| Lin, HC | 1 |
| Lee, HS | 1 |
| Chiueh, TS | 1 |
| Lin, YC | 2 |
| Lin, HA | 1 |
| Meng, E | 1 |
| Raison, NT | 1 |
| O'Brien, T | 1 |
| Game, D | 1 |
| Olsburgh, J | 1 |
| Wong, JH | 1 |
| Jang, MY | 3 |
| Huang, YS | 1 |
| Chang, WC | 2 |
| Liu, KM | 2 |
| Lai, PT | 1 |
| Lee, WM | 1 |
| Tam, YH | 1 |
| Song, M | 2 |
| Yu, HY | 2 |
| Chun, JY | 1 |
| Shin, DM | 2 |
| Song, SH | 1 |
| Choo, MS | 2 |
| Song, YS | 1 |
| Wein, AJ | 1 |
| Yek, J | 1 |
| Sundaram, P | 1 |
| Aydin, H | 1 |
| Kuo, T | 1 |
| Ng, LG | 1 |
| Kidger, E | 1 |
| Garthwaite, M | 1 |
| Schaeffer, EM | 1 |
| Rajandram, R | 1 |
| Ong, TA | 1 |
| Razack, AH | 1 |
| MacIver, B | 1 |
| Zeidel, M | 1 |
| Chancellor, MB | 1 |
| Shabir, S | 1 |
| Georgopoulos, NT | 1 |
| Kim, A | 1 |
| Heo, J | 1 |
| Shin, JH | 1 |
| Lim, J | 1 |
| Yoon, SJ | 1 |
| Kim, Y | 1 |
| Lee, S | 1 |
| Kim, SW | 1 |
| Oh, W | 1 |
| Choi, SJ | 1 |
| Wang, L | 1 |
| Liu, LF | 1 |
| Huang, YM | 1 |
| Tang, ZY | 1 |
| Myers, FA | 1 |
| Bluth, MH | 1 |
| Cheung, WW | 1 |
| Lee, KW | 1 |
| Kim, WB | 1 |
| Lee, SW | 1 |
| Kim, JH | 1 |
| Kim, JM | 1 |
| Kim, YH | 1 |
| Kim, ME | 1 |
| Lin, CC | 1 |
| Yang, AH | 1 |
| Lin, AT | 1 |
| Hoskins, R | 1 |
| Chen, LY | 1 |
| Chen, KP | 1 |
| Huang, MC | 1 |
| Oxley, JD | 2 |
| Cottrell, AM | 3 |
| Adams, S | 1 |
| Hopcroft, SA | 1 |
| Mason, K | 1 |
| Abrams, P | 1 |
| Morgan, CJ | 1 |
| Curran, HV | 1 |
| Chen, YL | 1 |
| Huang, GS | 1 |
| Wu, CJ | 1 |
| Castillo, C | 1 |
| Ventura, M | 1 |
| Lorente, JA | 1 |
| Bielsa, O | 1 |
| Arango, O | 1 |
| Lieb, M | 1 |
| Bader, M | 1 |
| Palm, U | 1 |
| Stief, CG | 1 |
| Baghai, TC | 1 |
| Chen, CH | 1 |
| Lee, MH | 1 |
| Lin, MF | 1 |
| Winstock, AR | 1 |
| Mitcheson, L | 1 |
| Gillatt, DA | 1 |
| Wei, Y | 1 |
| Song, W | 1 |
| Guo, Q | 1 |
| Jalil, R | 1 |
| Gupta, S | 1 |
| Gray, T | 1 |
| Dass, M | 1 |
| Li, YL | 1 |
| Lee, HH | 1 |
| Levin, RM | 1 |
| Méen, M | 1 |
| Coudoré-Civiale, MA | 1 |
| Parry, L | 1 |
| Eschalier, A | 1 |
| Boucher, M | 1 |
| Shahani, R | 2 |
| Streutker, C | 1 |
| Dickson, B | 1 |
| Stewart, RJ | 2 |
| Grégoire, MC | 1 |
| MacLellan, DL | 1 |
| Finley, GA | 1 |
| Wood, R | 1 |
| Eichel, L | 1 |
| Messing, EM | 1 |
| Schwarz, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of the Antidepressant Effects of Nitrous Oxide in People With Major Depressive Disorder[NCT05357040] | Phase 2 | 172 participants (Anticipated) | Interventional | 2021-06-30 | Recruiting | ||
| Intravesical Injection of Dextrose to Improve Lower Urinary Tract Symptoms Caused by Chronic Cystitis[NCT04821882] | 29 participants (Actual) | Interventional | 2019-05-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
12 reviews available for ketamine and Cystitis
| Article | Year |
|---|---|
Reviving Cav1.2 as an attractive drug target to treat bladder dysfunction.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cystitis; Drug Delivery Systems; Humans | 2022 |
Systematic review and meta-analysis of ketamine-associated uropathy.
Topics: Cystitis; Humans; Ketamine; Pain; Urinary Bladder; Urologic Diseases | 2022 |
Systematic review and meta-analysis of ketamine-associated uropathy.
Topics: Cystitis; Humans; Ketamine; Pain; Urinary Bladder; Urologic Diseases | 2022 |
Systematic review and meta-analysis of ketamine-associated uropathy.
Topics: Cystitis; Humans; Ketamine; Pain; Urinary Bladder; Urologic Diseases | 2022 |
Systematic review and meta-analysis of ketamine-associated uropathy.
Topics: Cystitis; Humans; Ketamine; Pain; Urinary Bladder; Urologic Diseases | 2022 |
Current approaches for the treatment of ketamine-induced cystitis.
Topics: Administration, Intravesical; Animals; Cystitis; Ketamine; Substance-Related Disorders | 2023 |
What urologists need to know about ketamine-induced uropathy: A systematic review.
Topics: Analgesics; Cystitis; Cystoscopy; Diagnosis, Differential; Humans; Ketamine; Substance-Related Disor | 2020 |
Molecular pathways underlying tissue injuries in the bladder with ketamine cystitis.
Topics: Cystitis; Gene Expression Regulation; Humans; Ketamine; Signal Transduction; Urinary Bladder | 2021 |
Rodent models of ketamine-induced cystitis.
Topics: Animals; Cystitis; Ketamine; Rodentia | 2021 |
[Diagnosis and treatment of ketamine-associated cystitis: a report of 3 cases and literature review].
Topics: Biopsy; Cystitis; Cystoscopy; Humans; Ketamine; Lower Urinary Tract Symptoms; Recurrence; Retrospect | 2013 |
Possible pathophysiology of ketamine-related cystitis and associated treatment strategies.
Topics: Acetylcholine Release Inhibitors; Anesthetics, Dissociative; Anti-Inflammatory Agents, Non-Steroidal | 2015 |
Ketamine: A Cause of Urinary Tract Dysfunction.
Topics: Analgesics; Cystitis; Diagnosis, Differential; Female; Humans; Ketamine; Lower Urinary Tract Symptom | 2016 |
Ketamine use: a review.
Topics: Abdominal Pain; Acute Disease; Anesthetics, Dissociative; Animals; Behavior, Addictive; Child; Chron | 2012 |
Ketamine-snorting associated cystitis.
Topics: Adult; Cystitis; Female; Humans; Ketamine; Male; Substance-Related Disorders; Young Adult | 2011 |
Ketamine cystitis: an emerging diagnostic and therapeutic challenge.
Topics: Cystitis; Diagnosis, Differential; Excitatory Amino Acid Antagonists; Humans; Illicit Drugs; Ketamin | 2012 |
72 other studies available for ketamine and Cystitis
| Article | Year |
|---|---|
Ketamine Cystitis: An Underrecognized Cause of Dysuria.
Topics: Cystitis; Dysuria; Humans; Ketamine; Substance-Related Disorders | 2022 |
Transcriptomic analysis of bladder tissue in a rat model of ketamine-induced bladder fibrosis.
Topics: Animals; Cystitis; Female; Fibrosis; Gene Expression Profiling; Humans; Ketamine; Male; Rats; Rats, | 2022 |
Specific Impacts of Ketamine on Bladder Dysfunction and Associated Histological Alterations in Rats-A Time Course Validation through Transmission Electron Microscopy.
Topics: Animals; Cystitis; Hypertrophy; Ketamine; Microscopy, Electron, Transmission; Rats; Rats, Sprague-Da | 2022 |
Intravesical hyaluronic acid therapy after bladder autoaugmentation by transurethral vesicomyotomy for ketamine cystitis: is it helpful?
Topics: Administration, Intravesical; Cystitis; Cystitis, Interstitial; Humans; Hyaluronic Acid; Ketamine; U | 2022 |
Therapeutic Effect of Platelet-Rich Plasma Improves Bladder Overactivity in the Pathogenesis of Ketamine-Induced Ulcerative Cystitis in a Rat Model.
Topics: Animals; Cystitis; Female; Humans; Ketamine; Platelet-Rich Plasma; Psychomotor Agitation; Rats; Rats | 2022 |
Upregulation of neurotrophins and transforming growth factor-β expression in the bladder may lead to nerve hyperplasia and fibrosis in patients with severe ketamine-associated cystitis.
Topics: Adult; Aged; Brain-Derived Neurotrophic Factor; Cystitis; Excitatory Amino Acid Antagonists; Female; | 2019 |
Ba-Wei-Die-Huang-Wan (Hachimi-jio-gan) can ameliorate ketamine-induced cystitis by modulating neuroreceptors, inflammatory mediators, and fibrogenesis in a rat model.
Topics: Animals; Collagen; Cyclooxygenase 2; Cystitis; Drugs, Chinese Herbal; Female; Fibronectins; Function | 2019 |
Ketamine induces endoplasmic reticulum stress in rats and SV-HUC-1 human uroepithelial cells by activating NLRP3/TXNIP aix.
Topics: Animals; Apoptosis; Carrier Proteins; Cell Cycle Proteins; Cell Line; Cystitis; Cytokines; Endoplasm | 2019 |
Extracellular vesicles enhance oxidative stress through P38/NF-kB pathway in ketamine-induced ulcerative cystitis.
Topics: Apoptosis; Cell Line, Tumor; Cell Survival; Cystitis; Cytochalasin D; Extracellular Vesicles; Humans | 2020 |
Disruption of Cav1.2-mediated signaling is a pathway for ketamine-induced pathology.
Topics: Animals; Calcium; Calcium Channels, L-Type; Cell Proliferation; Cystitis; Disease Models, Animal; Hu | 2020 |
Risk of Renal Function Decline in Patients with Ketamine-Associated Uropathy.
Topics: Adult; Analgesics; Cystitis; Female; Glomerular Filtration Rate; Humans; Hydronephrosis; Ketamine; K | 2020 |
Topics: Acute Kidney Injury; Cystitis; Humans; Ketamine | 2020 |
Recreational ketamine-induced cholangiopathy and ulcerative cystitis.
Topics: Adolescent; Anesthetics, Dissociative; Cholangitis; Cystitis; Humans; Ketamine; Male; Recreational D | 2021 |
Smaller bladder capacity and stronger bladder contractility in patients with ketamine cystitis are associated with elevated TRPV1 and TRPV4.
Topics: Adult; Cystitis; Female; Gene Expression Regulation; Humans; Ketamine; Male; Middle Aged; TRPV Catio | 2021 |
Ketamine enhances autophagy and endoplasmic reticulum stress in rats and SV-HUC-1 cells via activating IRE1-TRAF2-ASK1-JNK pathway.
Topics: Animals; Apoptosis; Autophagy; Cell Line; Cystitis; Disease Models, Animal; Endoplasmic Reticulum St | 2021 |
Ketamine-induced bladder fibrosis involves epithelial-to-mesenchymal transition mediated by transforming growth factor-β1.
Topics: Analgesics; Animals; Cell Line; Cystitis; Epithelial-Mesenchymal Transition; Female; Fibroblasts; Fi | 2017 |
Clinical Outcome of Augmentation Enterocystoplasty for Patients with Ketamine-induced Cystitis.
Topics: Adult; Cystitis; Female; Humans; Ketamine; Male; Retrospective Studies; Substance-Related Disorders; | 2017 |
Effective treatment of ketamine-associated cystitis with botulinum toxin type a injection combined with bladder hydrodistention.
Topics: Adult; Anesthetics, Dissociative; Botulinum Toxins, Type A; Cystitis; Female; Humans; Hydrotherapy; | 2017 |
Elucidating Mechanisms of Bladder Repair after Hyaluronan Instillation in Ketamine-Induced Ulcerative Cystitis in Animal Model.
Topics: Animals; Cystitis; Disease Models, Animal; Female; Hyaluronan Receptors; Hyaluronic Acid; Inflammati | 2017 |
Clinical significance of interleukin‑6 and inducible nitric oxide synthase in ketamine‑induced cystitis.
Topics: Aorta; Cyclophosphamide; Cystitis; Gene Expression Regulation; Humans; Interleukin-6; Ketamine; Myoc | 2018 |
The effects of recreational ketamine cystitis on urinary tract reconstruction - a surgical challenge.
Topics: Acute Kidney Injury; Adult; Anastomotic Leak; Anesthetics, Dissociative; Cystitis; Female; Humans; I | 2018 |
Vascular fibrinoid necrosis in the urinary bladder of ketamine abusers: A new finding that may provide a clue to the pathogenesis of ketamine-induced vesicopathy.
Topics: Adult; Cystitis; Female; Humans; Ketamine; Necrosis; Substance-Related Disorders; Urinary Bladder; U | 2019 |
Potential Orphan Drug Therapy of Intravesical Liposomal Onabotulinumtoxin-A for Ketamine-Induced Cystitis by Mucosal Protection and Anti-inflammation in a Rat Model.
Topics: Administration, Intravesical; Analgesics; Animals; Anti-Inflammatory Agents; Botulinum Toxins, Type | 2018 |
Complete reversal of the clinical symptoms and image morphology of ketamine cystitis after intravesical hyaluronic acid instillation: A case report.
Topics: Adjuvants, Immunologic; Administration, Intravesical; Adult; Analgesics; Cystitis; Cystoscopy; Diagn | 2018 |
Epigenetic regulation of COX‑2 expression by DNA hypomethylation via NF‑κB activation in ketamine‑induced ulcerative cystitis.
Topics: Animals; Chromatin Immunoprecipitation; CpG Islands; Cyclooxygenase 2; Cystitis; Disease Models, Ani | 2019 |
'Ketamine-induced ulcerative cystitis' is perhaps better labelled 'ketamine-induced uropathy'.
Topics: Anesthetics, Dissociative; Animals; Cystitis; Humans; Ketamine; Male; Memory Disorders; Substance-Re | 2013 |
Ketamine and damage to the urinary tract.
Topics: Anesthetics, Dissociative; Animals; Cystitis; Humans; Ketamine; Male; Memory Disorders; Substance-Re | 2013 |
'Addiction' in adolescence: who is really losing control?
Topics: Anesthetics, Dissociative; Animals; Cystitis; Humans; Ketamine; Male; Memory Disorders; Substance-Re | 2013 |
Augmentation enterocystoplasty is effective in relieving refractory ketamine-related bladder pain.
Topics: Adult; Anastomosis, Surgical; Chronic Pain; Cystitis; Female; Humans; Ileum; Ketamine; Male; Pilot P | 2014 |
Nerve hyperplasia: a unique feature of ketamine cystitis.
Topics: Adult; Aged; Aged, 80 and over; Anesthetics, Dissociative; Cystitis; Humans; Hyperplasia; Illicit Dr | 2013 |
[Urinary tract lesions associated to ketamine consumption].
Topics: Cystitis; Excitatory Amino Acid Antagonists; Humans; Illicit Drugs; Ketamine; Male; Substance-Relate | 2014 |
Chronic hematuria and abdominal pain.
Topics: Abdominal Pain; Adolescent; Chronic Disease; Common Bile Duct; Cystitis; Dilatation, Pathologic; Fem | 2014 |
Ketamine cystitis: practical considerations in management.
Topics: Adolescent; Adult; Cystitis; Female; Humans; Ketamine; Lower Urinary Tract Symptoms; Male; Middle Ag | 2014 |
Bilateral hydronephrosis and cystitis resulting from chronic ketamine abuse.
Topics: Analgesics; Anti-Bacterial Agents; Cystitis; Diagnosis, Differential; Humans; Hydronephrosis; Ketami | 2014 |
Long-term ketamine abuse induces cystitis in rats by impairing the bladder epithelial barrier.
Topics: Animals; Biomarkers; Blotting, Western; Cystitis; Dose-Response Relationship, Drug; Epithelium; Hist | 2014 |
Histopathological assessment of inflammation and expression of inflammatory markers in patients with ketamine-induced cystitis.
Topics: Adolescent; Adult; Analgesics; Biomarkers; Cystitis; Female; Humans; Immunohistochemistry; Inflammat | 2015 |
Autotransplantation for the management of ketamine ureteritis.
Topics: Adult; Biopsy; Cystectomy; Cystitis; Cystoscopy; Humans; Ketamine; Male; Transplantation, Autologous | 2015 |
Translocation of NF-κB and expression of cyclooxygenase-2 are enhanced by ketamine-induced ulcerative cystitis in rat bladder.
Topics: Animals; Cell Line; Cyclooxygenase 2; Cystitis; Female; Humans; Ketamine; NF-kappa B; Protein Transp | 2015 |
Ketamine-induced ulcerative cystitis and bladder apoptosis involve oxidative stress mediated by mitochondria and the endoplasmic reticulum.
Topics: Animals; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Biomarkers; Cystitis; Disease Model | 2015 |
Editorial Comment to Possible pathophysiology of ketamine-related cystitis and associated treatment strategies.
Topics: Anesthetics, Dissociative; Cystitis; Humans; Ketamine; Urinary Bladder | 2015 |
Clinical Outcome of a Prospective Case Series of Patients With Ketamine Cystitis Who Underwent Standardized Treatment Protocol.
Topics: Adult; Clinical Protocols; Cystitis; Excitatory Amino Acid Antagonists; Female; Humans; Ketamine; Ma | 2015 |
The fibrosis of ketamine, a noncompetitive N-methyl-d-aspartic acid receptor antagonist dose-dependent change in a ketamine-induced cystitis rat model.
Topics: Animals; Cystitis; Disease Models, Animal; Dose-Response Relationship, Drug; Excitatory Amino Acid A | 2016 |
Re: Long-Term Ketamine Abuse Induces Cystitis in Rats by Impairing the Bladder Epithelial Barrier.
Topics: Animals; Cystitis; Epithelium; Ketamine; Substance-Related Disorders; Urinary Bladder | 2016 |
The clinical presentation and diagnosis of ketamine-associated urinary tract dysfunction in Singapore.
Topics: Adult; Cystitis; Cystoscopy; Female; Fluoroscopy; Humans; Ketamine; Lower Urinary Tract Symptoms; Ma | 2015 |
A Rare Urachal Cyst in a Case of Ketamine-induced Cystitis Provides Mechanistic Insights.
Topics: Adult; Cystitis; Humans; Ketamine; Male; Urachal Cyst | 2016 |
Re: Ketamine Cystitis: Practical Considerations in Management.
Topics: Cystitis; Female; Humans; Ketamine; Lower Urinary Tract Symptoms; Male; Substance-Related Disorders | 2016 |
Intact urothelial barrier function in a mouse model of ketamine-induced voiding dysfunction.
Topics: Anesthetics, Dissociative; Animals; Cystitis; Female; Ketamine; Mice; Mice, Inbred C57BL; Permeabili | 2016 |
Patient characteristics for different therapeutic strategies in the management ketamine cystitis.
Topics: Adolescent; Adult; Conservative Treatment; Cystitis; Female; Humans; Ketamine; Male; Retrospective S | 2017 |
Ketamine-Induced Apoptosis in Normal Human Urothelial Cells: A Direct, N-Methyl-d-Aspartate Receptor-Independent Pathway Characterized by Mitochondrial Stress.
Topics: Analgesics; Apoptosis; Calcium Signaling; Cells, Cultured; Cystitis; Dose-Response Relationship, Dru | 2016 |
Mesenchymal stem cells protect against the tissue fibrosis of ketamine-induced cystitis in rat bladder.
Topics: Analgesics; Animals; Cells, Cultured; Cystitis; Disease Models, Animal; Fibrosis; Humans; Infant, Ne | 2016 |
Letter to the editor: "Urothelial barrier dysfunction: cause or outcome of ketamine-induced voiding dysfunction".
Topics: Cystitis; Humans; Ketamine; Urothelium | 2016 |
Reply to "Letter to the editor: 'Urothelial barrier dysfunction: cause or outcome of ketamine-induced voiding dysfunction'".
Topics: Cystitis; Humans; Ketamine; Urothelium | 2016 |
The putative involvement of actin-binding proteins and cytoskeleton proteins in pathological mechanisms of ketamine cystitis-Revealed by a prospective pilot study using proteomic approaches.
Topics: Actins; Adult; Cystitis; Cytoskeletal Proteins; Female; Humans; Ketamine; Male; Middle Aged; Pilot P | 2017 |
Alterations of Macrophage Migration Inhibitory Factor Expression in the Nervous System of the Rat Cystitis Model.
Topics: Animals; Cystitis; Disease Models, Animal; Female; Immunohistochemistry; Inflammation; Intramolecula | 2017 |
Activation of the mTOR dependent signaling pathway underlies ketamine-induced uropathy.
Topics: Adult; Cystitis; Female; Humans; Ketamine; Male; Microvessels; Middle Aged; Phosphorylation; Ribosom | 2017 |
Ketamine associated cystitis - a case report.
Topics: Adult; Anti-Infective Agents; Ciprofloxacin; Cystitis; Cystoscopy; Emergency Treatment; Humans; Keta | 2009 |
Cystitis associated with chronic ketamine abuse.
Topics: Chronic Disease; Cystitis; Female; Humans; Ketamine; Male; Substance-Related Disorders | 2009 |
Ketamine cystitis as a mimic of carcinoma in situ.
Topics: Adult; Biomarkers, Tumor; Carcinoma; Cystitis; Diagnosis, Differential; Female; Humans; Immunohistoc | 2009 |
Ureteric intestinal metaplasia in association with chronic recreational ketamine abuse.
Topics: Adult; Anesthetics, Dissociative; Cystitis; Humans; Intestines; Ketamine; Male; Metaplasia; Spina Bi | 2011 |
Ketamine-associated vesicopathy.
Topics: Adolescent; Analgesics; Biopsy; Cystitis; Cystoscopy; Diagnosis, Differential; Disease Management; H | 2012 |
[Cystitis and ketamine associated bladder dysfunction].
Topics: Adolescent; Adult; Cross-Sectional Studies; Cystitis; Dose-Response Relationship, Drug; Excitatory A | 2012 |
[Ketamine-induced vesicopathy].
Topics: Administration, Intranasal; Administration, Intravesical; Adult; Analgesics; Botulinum Toxins, Type | 2012 |
The prevalence and natural history of urinary symptoms among recreational ketamine users.
Topics: Abdominal Pain; Adult; Anesthetics, Dissociative; Cohort Studies; Cystitis; Female; Humans; Illicit | 2012 |
Gourd-shaped bladder associated with ketamine abuse.
Topics: Adult; Cystitis; Dysuria; Hematuria; Humans; Illicit Drugs; Ketamine; Lower Urinary Tract Symptoms; | 2012 |
Illicit ketamine and its bladder consequences: is it irreversible?
Topics: Adult; Anesthetics, Dissociative; Cystitis; Female; Humans; Illicit Drugs; Ketamine; Lower Urinary T | 2012 |
Dual involvements of cyclooxygenase and nitric oxide synthase expressions in ketamine-induced ulcerative cystitis in rat bladder.
Topics: Animals; Cystitis; Ketamine; Nitric Oxide Synthase; Prostaglandin-Endoperoxide Synthases; Rats; Rats | 2013 |
Effects of long-term ketamine administration on rat bladder protein levels: a proteomic investigation using two-dimensional difference gel electrophoresis system.
Topics: Anesthetics, Dissociative; Animals; Cystitis; Electrophoresis, Gel, Two-Dimensional; Ketamine; Male; | 2013 |
Involvement of N-methyl-D-aspartate receptors in nociception in the cyclophosphamide-induced vesical pain model in the conscious rat.
Topics: Acrolein; Animals; Antineoplastic Agents, Alkylating; Behavior, Animal; Cyclophosphamide; Cystitis; | 2002 |
Ketamine-associated ulcerative cystitis: a new clinical entity.
Topics: Adult; Biopsy, Needle; Cystitis; Cystoscopy; Female; Follow-Up Studies; Humans; Ketamine; Male; Pent | 2007 |
Reply to letter-to-the-editor, Re: Shahani R, Streutker C, Dickson B, et al: Ketamine-associated ulcerative cystitis: a new clinical entity. Urology 69: 810-812, 2007.
Topics: Analgesics; Cystitis; Humans; Ketamine; Ulcer | 2008 |
A pediatric case of ketamine-associated cystitis (Letter-to-the-Editor RE: Shahani R, Streutker C, Dickson B, et al: Ketamine-associated ulcerative cystitis: a new clinical entity. Urology 69: 810-812, 2007).
Topics: Adolescent; Analgesics; Cystitis; Female; Humans; Ketamine | 2008 |
Automated noninvasive measurement of cyclophosphamide-induced changes in murine micturition frequency and volume and demonstration of pharmacologic sensitivity.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics | 2001 |